Entire Site
Articles/Fact Sheets
Ask the Experts
Conference Coverage
Now Live:
Breaking Research From AIDS 2008: Podcasts, Interviews, Videos & More >>
HIV/AIDS Basics & Prevention
HIV/AIDS Basics & Prevention
Basics & Prevention: Home
HIV/AIDS Basics
HIV Prevention
HIV Testing
Who Gets HIV/AIDS?
Myths About HIV/AIDS
More ...
Just Diagnosed
Just Diagnosed
Just Diagnosed: Home
Choosing a Physician
Coping
HIV Hotlines & Orgs
Telling Others
More ...
HIV Treatment
HIV Treatment
HIV Treatment: Home
Drug Resistance
HIV Medications
Side Effects & Health Problems
Starting Treatment
Women & Pregnancy
More ...
Living With HIV
Living With HIV
Living With HIV: Home
Arts & Entertainment
Beyond Medications
Inspiring Stories
Mental Health
More ...
AIDS Policy & Activism
AIDS Policy & Activism
HIV Policy & Activism: Home
Activist Central
Medicine Recycling
U.S.-Specific News
Developing World News
More ...
HIV Around the World
HIV Around the World
HIV Around the World: Home
Africa
Asia
Latin America
U.S. and Canada
Western Europe
More ...
Conference Coverage
Conference Coverage
Conference Coverage: Home
IDSA 2007
ICAAC 2007
Previous Conferences
Upcoming Conferences
More ...
Treatment Action Group
Table of Contents
October 2003
Slice of Pie: Global Market Share for HIV Drugs
GSK
45%
BMS
23%
Abbott
13%
Merck
5%
Pfizer
5%
BI, Gilead, Roche
9%
Source: IMS Health; Evaluate Pharma
Contents:
The Diabolic Science: VaxGen's Claims of Vaccine Efficacy Evanesce in Autumn's Last Light
By Richard Jefferys
Medi Gap: Congressional Juggling of Medicare Drug Coverage Leaves Many in the Lurch
Letter to President Bush
By William E. Arnold, Mark Harrington and A. Cornelius Baker
This article was provided by
Treatment Action Group
.
It is a part of the publication
TAGline
.